Device
ClearSight™ System
ClearSight™ System is a medical device with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(2)
Terminated(1)
Detailed Status
Completed2
Recruiting1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A1 (100.0%)
Trials by Status
recruiting125%
withdrawn125%
completed250%
Recent Activity
1 active trials
Showing 4 of 4
withdrawn
Passive Leg Raising in Term Pregnancy on Hemodynamic Monitoring - Validating With Transthoracic ECHO (LG-ECHO)
NCT07253818
recruiting
Non-Invasive Blood Pressure Monitoring
NCT05825937
completed
Exploratory Study Comparing ClearSight System 2D Map to Post Surgery Histopathological Analysis in Lumpectomy
NCT02679378
completednot_applicable
Noninvasive Continuous Blood Pressure Monitoring for Cesarean Delivery
NCT04752904
Clinical Trials (4)
Showing 4 of 4 trials
NCT07253818
Passive Leg Raising in Term Pregnancy on Hemodynamic Monitoring - Validating With Transthoracic ECHO (LG-ECHO)
NCT05825937
Non-Invasive Blood Pressure Monitoring
NCT02679378
Exploratory Study Comparing ClearSight System 2D Map to Post Surgery Histopathological Analysis in Lumpectomy
NCT04752904Not Applicable
Noninvasive Continuous Blood Pressure Monitoring for Cesarean Delivery
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4